Pearl River Capital, LLC Bio Techne Corp Transaction History

Pearl River Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$62.12 - $84.15 $1.84 Million - $2.5 Million	29,680 New	29,680 $2.13 Million
Q1 2023 May 12, 2023	BUY	$71.62 - $86.62 $273,015 - $330,195	3,812 New	3,812 $282,000
Q3 2022 Nov 14, 2022	SELL	$282.54 - $391.85 $117,536 - $163,009	-416 Reduced 29.17%	1,010 $287,000
Q2 2022 Aug 12, 2022	BUY	$322.67 - $449.65 $32,267 - $44,965	100 Added 7.54%	1,426 $494,000
Q1 2022 May 13, 2022	BUY	$353.85 - $487.79 $24,769 - $34,145	70 Added 5.57%	1,326 $574,000
Q4 2021 Feb 11, 2022	SELL	$456.15 - $525.06 $173,337 - $199,522	-380 Reduced 23.23%	1,256 $650,000
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $727,807 - $881,607	1,636 New	1,636 $793,000
Q1 2019 May 02, 2019	SELL	$136.09 - $200.44 $22,999 - $33,874	-169 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$132.75 - $203.8 $22,434 - $34,442	169 New	169 $24,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.79B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.